Cargando…
P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430955/ http://dx.doi.org/10.1097/01.HS9.0000971512.00634.8e |
| _version_ | 1785091083777081344 |
|---|---|
| author | Thieblemont, Catherine Fox, Christopher Wang, Anthony Sail, Kavita Alshreef, Abualbishr Moran, Michael Mutebi, Alex Blaedel, Julie Chirikov, Viktor Salles, Gilles |
| author_facet | Thieblemont, Catherine Fox, Christopher Wang, Anthony Sail, Kavita Alshreef, Abualbishr Moran, Michael Mutebi, Alex Blaedel, Julie Chirikov, Viktor Salles, Gilles |
| author_sort | Thieblemont, Catherine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430955 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309552023-08-17 P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON Thieblemont, Catherine Fox, Christopher Wang, Anthony Sail, Kavita Alshreef, Abualbishr Moran, Michael Mutebi, Alex Blaedel, Julie Chirikov, Viktor Salles, Gilles Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430955/ http://dx.doi.org/10.1097/01.HS9.0000971512.00634.8e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Thieblemont, Catherine Fox, Christopher Wang, Anthony Sail, Kavita Alshreef, Abualbishr Moran, Michael Mutebi, Alex Blaedel, Julie Chirikov, Viktor Salles, Gilles P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_full | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_fullStr | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_full_unstemmed | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_short | P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON |
| title_sort | p1154: efficacy of subcutaneous epcoritamab vs axi-cel in r/r dlbcl car t-naive and car t-eligible patients: an indirect comparison |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430955/ http://dx.doi.org/10.1097/01.HS9.0000971512.00634.8e |
| work_keys_str_mv | AT thieblemontcatherine p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT foxchristopher p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT wanganthony p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT sailkavita p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT alshreefabualbishr p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT moranmichael p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT mutebialex p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT blaedeljulie p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT chirikovviktor p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison AT sallesgilles p1154efficacyofsubcutaneousepcoritamabvsaxicelinrrdlbclcartnaiveandcarteligiblepatientsanindirectcomparison |